25I-NB3OMe

25I-NB3OMe is a psychedelic and hallucinogenic drug that is part of the 2C family. It is a derivative of the phenethylamine discovered by Alexander Shulgin. The drug is also related to other psychedelic phenethylamines such as 25I-NBOMe.

Chemistry

25I-NB3OMe is a phenethylamine derivative and shares a similar chemical structure with other psychedelic phenethylamines like 25I-NBOMe. The chemical structure consists of a phenyl ring bound to an amino (NH2) group through an ethyl chain with the nitrogen(N) of the NH2 group substituted with 2,5-dimethoxy-3-bromophenethyl.

Pharmacology

The exact mechanism of action of 25I-NB3OMe is not fully understood. However, it is known to act as a potent partial agonist for the 5-HT2A receptor, which is thought to be the primary target for hallucinogenic drugs. The drug may also interact with other serotonin receptors, contributing to its psychedelic effects.

Effects

The effects of 25I-NB3OMe can vary greatly depending on the dose, individual physiology, and set and setting. Common effects reported by users include intense visual hallucinations, euphoria, time distortion, and introspection. Negative effects can include anxiety, paranoia, and dangerous changes in heart rate and blood pressure.

Legality

The legality of 25I-NB3OMe varies by country. In many countries, including the United States, it is a controlled substance due to its potential for abuse and lack of accepted medical use.

See also

• 25I-NBOMe
• 2C-I
• Psychedelic drug
• Hallucinogen